Alpha 2.0
Login Register
» Articles » PMID: 16015385

Fusion of NUP214 to ABL1 on Amplified Episomes in T-ALL--implications for Treatment

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2005 Jul 15
PMID 16015385
Citations 10
Authors
K Stergianou
C Fox
N H Russell
Affiliations
Soon will be listed here.
Citing Articles

Clinical, Phenotypic and Molecular Characterization of Fusion Positive Myeloid Malignancies.

Wakefield C, Hansen Smith M, Dashkevych U, Proytcheva M, Khurana S J Med Cases. 2024; 15(9):250-255.

PMID: 39205695 PMC: 11349118. DOI: 10.14740/jmc4286.

Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic :: Gene Fusion.

Stukaite-Ruibiene E, Norvilas R, Dirse V, Stankeviciene S, Vaitkeviciene G Pathol Oncol Res. 2022; 28:1610570.

PMID: 36172171 PMC: 9510372. DOI: 10.3389/pore.2022.1610570.

Case Report: The First Report of Fusion Gene in Acute Myeloid Leukemia Patient Detected by Next-Generation Sequencing.

Wang H, He J, Zhu Q, Wang L, Li J, Huang J Front Oncol. 2021; 11:706798.

PMID: 34307175 PMC: 8295748. DOI: 10.3389/fonc.2021.706798.

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms.

Rack K, van den Berg E, Haferlach C, Beverloo H, Costa D, Espinet B Leukemia. 2019; 33(8):1851-1867.

PMID: 30696948 PMC: 6756035. DOI: 10.1038/s41375-019-0378-z.

Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.

Vanden Bempt M, Demeyer S, Broux M, De Bie J, Bornschein S, Mentens N Cancer Cell. 2018; 34(2):271-285.e7.

PMID: 30107177 PMC: 6097876. DOI: 10.1016/j.ccell.2018.07.007.